This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jim Cramer's 'Mad Money' Recap: Market Reset

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- The markets are in reset mode, Jim Cramer said on "Mad Money"  Monday after another down day on Wall Street. That means investors need to sit tight and wait before starting to pick through the rubble.

Cramer said the markets are working like clockwork, digesting bad news exactly as they're supposed to do. Things were set into motion after the last non-farm payroll numbers signaled the beginning of a possible reversal. That news was followed by news that auto inventories are building, commercial construction may be stalling and retail sales are falling off a cliff. These sectors were driving the markets in 2013 but have all but vaporized this year, Cramer explained.

All of this bad news caused professional money managers to shift gears, rotating into technology, the financials and industrials. But with China seemingly on shaky ground and tech companies also showing signs of weakness, fund managers are once again shifting positions, sending stocks into a tailspin.

Cramer said he doesn't feel that our economy is headed back into recession, but that doesn't mean investors should be jumping back into the markets quite yet. He said major moves like this one take a few days to play out, and only then will it be safe to get back in.

As for what to buy into, Cramer said that stocks creating their own destinies through mergers and acquisitions and those with activist-investor attention are two areas that will quickly able to reverse the market's slide over the past week.

Thriving Biotech

As the markets continue to sell off, there's one sector that's only getting more attractive, Cramer told viewers -- biotech. He said the biotech stocks thrive in slowing economic times. Investors just need to wait for the short-sellers to get flushed out before jumping back on the biotech bandwagon.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,071.22 -41.93 -0.24%
S&P 500 1,977.80 -5.05 -0.25%
NASDAQ 4,505.8520 -6.3420 -0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs